Tag Archives: labeling change

Statin Drugs Drug Safety Communication Class Labeling Change

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese Statin Drugs – Drug Safety Communication: Class Labeling Change AUDIENCE: Cardiology, Family Practice, Patients ISSUE: FDA has approved important safety label changes for the class of cholesterol-lowering drugs known … Continue reading

Share
Posted in Cardiology, Family Practice, FDA 2012, FDA Label Change, FDA Safety Communication | Tagged , , , , , , , , , , , , , , , , , , , , , | Comments Off

December 2011 Safety Labeling Change

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseThe MedWatch December 2011 Safety Labeling Changes posting includes 40 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and PATIENT PACKAGE INSERT. … Continue reading

Share
Posted in FDA 2011, FDA Label Change, FDA Warning | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Antipsychotic drugs: Class Labeling Change – Treatment During Pregnancy and Potential Risk to Newborns

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseAntipsychotic drugs: Class Labeling Change – Treatment During Pregnancy and Potential Risk to Newborns including Haldol, FazaClo, Fanapt, Clozaril, Risperdal, Zyprexa, Seroquel, Abilify, Geodon, Invega, Loxitane, Moban, Navane, Orap, Saphris, … Continue reading

Share
Posted in FDA Warning | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off